Iguratimod
12 Inquiries
123663-49-0
2026-08-10
D-Biotin,Tobramycin base,L(-)-Carnitine base,Polymyxin B sulfate USP,Kanamycin sulfate monohydrate,Finasteride 99% USP
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionKeywordsQuick DetailsProName:
Iguratimod
CasNo:123663-49-0
Molecular Formula:C17H14N2O6S
Appearance:White Floccular fibre powder
Application:Pharmaceutical raw materials
DeliveryTime:prompt shipment
PackAge:25kg/drum
Port:Hangzhou,Shanghai,China
ProductionCapacity:/
Purity:98.5%min
Storage:cool and dry
Transportation:by sea ,air or express
LimitNum:1 Kilogram
Superiority
Appearance： White to pale yellow floccularfibre powder Solubility： - In dimethylsulfoxide：Soluble - -In acetone, Ethyl …
Details
Appearance：
White to pale yellow floccular fibre powder
Solubility：
- In dimethylsulfoxide：Soluble
- -In acetone, Ethyl acetate,chloroform：Slightly soluble
- -In methanol：Sparingly soluble
- -In water, ethanol：Insoluble
ID
- By IR：Similar to standard
Melting Point： 237 ~ 241 ℃
Loss on Drying ：Not more than 2.0%
SulfatedAsh ：Not more than 0.15%
Heavy metals： Not more than 10PPM
Related Substances：
- Total Impurity：Not more than 1.0%
- Individual Impurity：Not more than 0.5%
Assay (HPLC)： More than 98.5%
Basic Info-
Product Name:
Iguratimod
Other Name:Methanesulfonamide,N-[3-(formylamino)-4-oxo-6-phenoxy-4H-1-benzopyran-7-yl]-;N-[3-(Formylamino)-4-oxo-6-phenoxy-4H-1-benzopyran-7-yl]methanesulfonamide;T 614;3-Formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-one;Iguratimod;N-[3-(Formylamino)-4-oxo-6-phenoxy-4H-chromen-7-yl]methanesulfonamide;T 614 (antiinflammatory);Careram;Kolbet
CAS No.:123663-49-0
Molecular Formula:C17H14N2O6S
InChIKeys:InChIKey=ANMATWQYLIFGOK-UHFFFAOYSA-N
Molecular Weight:374.37
Exact Mass:374.37
EC Number:1308068-626-2
UNII:4IHY34Y2NV
DSSTox ID:DTXSID0048971
HScode:2935009090
Categories:
Characteristics-
PSA:
119
XLogP3:1.4
Density:1.52±0.1 g/cm3(Predicted)
Melting Point:238.0 to 242.0 °C
Boiling Point:580.6±60.0 °C(Predicted)
Flash Point:304.9±32.9 °C
Refractive Index:1.674
Hazard IdentificationClassification of the substance or mixture
Reproductive toxicity, Category 2
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Warning
Hazard statement(s) H361 Suspected of damaging fertility or the unborn child
Precautionary statement(s) Prevention P203 Obtain, read and follow all safety instructions before use.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
Response P318 IF exposed or concerned, get medical advice.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
D-Biotin,Tobramycin base,L(-)-Carnitine base,Polymyxin B sulfate USP,Kanamycin sulfate monohydrate,Finasteride 99% USP
-
Location:
1613 Guangyin Building,No.42 E.Fengqi Road,Hangzhou,310012 China.
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
7
-
Total Annual Revenue:
$25 million-$50 million
-
Total Employees:
11-50
-
Year of Establishment:
2011
-
-
Inquiry History12 Inquiries
Country Product Purchase Quantity Date Posted 
India
Iguratimod
1.00 KG Jan 19, 2024
India
Iguratimod
4 KG Jul 21, 2025
India
Iguratimod
100.00 KG Aug 28, 2024
India
Iguratimod
100.00 KG Aug 5, 2024
India
Iguratimod
100.00 KG Aug 2, 2024
India
Iguratimod
500 KG May 16, 2024
India
Febuxostat
1.00 KG Jan 19, 2024
India
Linagliptin
1.00 KG Jan 19, 2024
India
URSODEOXYCHOLIC ACID
10.00 KG Mar 6, 2024
India
Acarbose
10.00 KG Mar 6, 2024
India
Upadacitinib
10.00 KG Mar 6, 2024
India
Ripretinib
10.00 KG Mar 6, 2024 Post an enquiry for this product